Roxana Redis, Associate Science Director of Advanced Modalities, Charles River Laboratories, talks about the exciting field of RNA.

Take a look at the latest examples of how pharma and its partners are working together to develop technology to solve key challenges.

In the final quarter of the year, how can pharmaceutical teams make their final budget decisions count?

The former Baxter leader talks about the founding of Vantive, the challenges facing kidney patients, improving access to dialysis and more.

Ever wondered what one of the world’s top oncology leaders believes to be the next big thing in cancer care? Find out in our interview AstraZeneca’s Dr Sunil Verma.

What key compliance considerations should pharma companies keep in mind before releasing new research in the US market, and how can they avoid compliance pitfalls?

Video is a powerful tool because it extends the reach of a live event, but does a recording ever live up to the event itself? Enter 3D interactive video.

AI is becoming less of a buzzword for those in the pharma industry. For medical affairs teams, how will it transform the function’s future?